Aura Biosciences, Inc. (AURA) Institutional Ownership & Insider Trading
146 institutions reported holding Aura Biosciences, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 14 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AURAAura Biosciences, Inc.Follow AURA — free
—
Price chart with a free account
- Market cap
- 653.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters146 institutions held 94.8% of the shares. Across filers that reported both quarters, shares held changed +88.4%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 146 | 98 | +88.4% | 56 | 34 | 26 | 12 |
| Mar 26 | 126 | 51 | +1.1% | 37 | 18 | 39 | 12 |
| Dec 25 | 117 | 50 | -2.9% | 33 | 17 | 32 | 8 |
| Sep 25 | 104 | 52 | +1.7% | 31 | 12 | 21 | 12 |
| Jun 25 | 104 | 51 | +27.3% | 31 | 25 | 30 | 13 |
| Mar 25 | 93 | 39 | -0.4% | 27 | 12 | 27 | 12 |
| Dec 24 | 94 | 39 | +5.5% | 34 | 16 | 14 | 7 |
| Sep 24 | 81 | 37 | -11.2% | 29 | 8 | 21 | 3 |
Aura Biosciences, Inc. — questions
- Who owns Aura Biosciences, Inc. stock?
- 146 institutions reported Aura Biosciences, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: TCG Crossover Management, LLC (9.2%), SUVRETTA CAPITAL MANAGEMENT, LLC (7.0%), Frazier Life Sciences Management, L.P. (6.8%).
- Are Aura Biosciences, Inc. insiders buying or selling?
- 14 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Aura Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.